In focus · trending topic

tumor cancers

1 stories · following the connections

PROVECTUS BIOPHARMACEUTICALS RECEIVES SECOND CANCER COMBINATION THERAPY PATENT FROM THE UNITED STATES PATENT AND TRADEMARK OFFICE

By Nasdaq OMXNov 7, 2017, 9:00 PM UTC